(2S,4R)-1-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-4-fluoro-5-oxopyrrolidine-2-carboxylic acid
C13H24FNO4Si — CID 142327833
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S,4R)-1-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-4-fluoro-5-oxopyrrolidine-2-carboxylic acid
(2S,4R)-1-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-4-fluoro-5-oxopyrrolidine-2-carboxylic acid (PubChem CID 142327833) has the molecular formula C13H24FNO4Si and a molecular weight of 305.42 g/mol. Its IUPAC name is (2S,4R)-1-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-4-fluoro-5-oxopyrrolidine-2-carboxylic acid.
Molecular Properties
| Compound Name | (2S,4R)-1-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-4-fluoro-5-oxopyrrolidine-2-carboxylic acid |
|---|---|
| PubChem CID | 142327833 |
| Molecular Formula | C13H24FNO4Si |
| Molecular Weight | 305.42 g/mol |
| Exact Mass | 305.15 |
| IUPAC Name | (2S,4R)-1-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-4-fluoro-5-oxopyrrolidine-2-carboxylic acid |
| SMILES | CC(C)(C)[Si](C)(C)OCCN1C(=O)[C@H](F)C[C@H]1C(=O)O |
| InChI | InChI=1S/C13H24FNO4Si/c1-13(2,3)20(4,5)19-7-6-15-10(12(17)18)8-9(14)11(15)16/h9-10H,6-8H2,1-5H3,(H,17,18)/t9-,10+/m1/s1 |
| InChIKey | LKRSUAQFICYFNU-ZJUUUORDSA-N |
| XLogP | 2.03 |
| TPSA | 66.84 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 20 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 305.42 |
| LogP ≤ 5 | 2.03 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142327833 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.